More than 1,000 researchers, clinicians and mental health advocates are expected to attend the Seventh International Conference on Bipolar Disorder, June 7-9 at the David L. Lawrence Convention Center in Pittsburgh.
More than 215,000 people will die of sepsis in the United States each year, more than 750,000 will require hospital treatment, and the costs will be nearly $17 billion.
The Southwest Oncology Group, the largest of several National Cancer Institute-sponsored clinical trials networks, has permanently closed enrollment in a trial comparing a standard drug therapy, dexamethasone, with a combined therapy of the same drug plus the drug lenalidomide (Revlimid) for people newly diagnosed with multiple myeloma.
A Web-based program that provides prostate cancer patients with information about different treatment approaches may make deciding which path to follow a little easier, Medical College of Georgia researchers say.
Can you imagine an archer trying to improve her accuracy by practicing blindfolded, never seeing how close she was to hitting her target, never getting any information to help correct her aim”
When singer/songwriter/guitarist Doug Fieger, lead singer of The Knack, found out last year that he had two brain tumors, he was concerned that either the tumors or the side effects of surgery would leave him unable to pursue his livelihood.
Researchers at the Ontario Cancer Institute at Princess Margaret Hospital have successfully proven that cancer cells alone can be killed by a new cancer drug that is triggered by a laser light, a process known as photodynamic therapy (PDT).
Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women?s Health Initiative that HRT may increase the risk of breast cancer and heart disease.
A glucosamine-like dietary supplement has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus, according to University of California, Irvine health sciences researchers.
Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.